References
- RobertsonFMBondyMYangWInflammatory breast cancer: the disease, the biology, the treatmentCA Cancer J Clin201060635137520959401
- AndersonWFSchairerCChenBEHanceKWLevinePHEpidemiology of inflammatory breast cancer (IBC)Breast Dis2005–200622923
- VegaFMRidleyAJRho GTPases in cancer cell biologyFEBS Lett2008582142093210118460342
- JaffeABHallARho GTPases: biochemistry and biologyAnnu Rev Cell Dev Biol20052124726916212495
- HakemASanchez-SweatmanOYou-TenARhoC is dispensable for embryogenesis and tumor initiation but essential for metastasisGenes Dev200519171974197916107613
- ClarkEAGolubTRLanderESHynesROGenomic analysis of metastasis reveals an essential role for RhoCNature2000406679553253510952316
- LinMDiVitoMMMerajverSDBoyanapalliMvan GolenKLRegulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1Mol Cancer2005412115969750
- WangWYangLYHuangGWGenomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosisBr J Cancer200490122349235515150600
- van GolenKLWuZFQiaoXTBaoLWMerajverSDRhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotypeCancer Res200060205832583811059780
- MaLTeruya-FeldsteinJWeinbergRATumour invasion and metastasis initiated by microRNA-10b in breast cancerNature2007449716368268817898713
- van GolenKLBaoLWPanQMillerFRWuZFMerajverSDMitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancerClin Exp Metastasis200219430131112090470
- PilléJYDenoyelleCVaretJAnti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivoMol Ther200511226727415668138
- SuwaHOhshioGImamuraTOverexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreasBr J Cancer19987711471529459160
- XieSZhuMLvGZhangQWangGThe role of RhoC in the proliferation and apoptosis of hepatocellular carcinoma cellsMed Oncol20122931802180921674277
- DorsettYTuschlTsiRNAs: applications in functional genomics and potential as therapeuticsNat Rev Drug Discov20043431832915060527
- AshiharaEKawataEMaekawaTFuture prospect of RNA interference for cancer therapiesCurr Drug Targets201011334536020210759
- GondiCSRaoJSConcepts in in vivo siRNA delivery for cancer therapyJ Cell Physiol2009220228529119391103
- HossbachMGruberJOsbornMWeberKTuschlTGene silencing with siRNA duplexes composed of target-mRNA-complementary and partially palindromic or partially complementary single-stranded siRNAsRNA Biol200632828917114944
- CroftDROlsonMFThe Rho GTPase effector ROCK regulates cyclin A, cyclin D1, and p27Kip1 levels by distinct mechanismsMol Cell Biol200626124612462716738326
- KleerCGTeknosTNIslamMRhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neckClin Cancer Res200612154485449016899593
- JacksonPMarreirosARussellPJKAI1 tetraspanin and metastasis suppressorInt J Biochem Cell Biol200537353053415618009
- BeiderKAbrahamMBeginMInteraction between CXCR4 and CCL20 pathways regulates tumor growthPLoS One200944e512519340288
- SmithMCLukerKEGarbowJRCXCR4 regulates growth of both primary and metastatic breast cancerCancer Res200464238604861215574767
- MehnerCHocklaAMillerERanSRadiskyDCRadiskyESTumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancerOncotarget2014592736274924811362